| |
Targeted Selection: Ockham is selective and disciplined about what it takes on, and is therefore able to target the kind of companies it works with. By targeting its high-quality, customer-focused services – in the areas of regulatory, medical writing, data management, project management, medical monitoring and safety management, clinical monitoring, and biostatistics – to carefully vetted small and emerging biotechnology and pharmaceutical customers only, Ockham focuses and matches its strengths to the client’s specific needs.
Structured Assessment: Ockham applies a variety of internal benchmarks and metrics in the assessment of Sponsor protocols, projects, and processes. This careful, content-oriented review yields information that is critical to successful selection and partnering.
Realistic Planning: Based on the content-oriented review and assessment, Ockham crafts detailed plans for executing the project. Depending on need, this may include in-house development services and strategic consulting services – both internally and through Ockham’s partnership with complementary drug development experts and external services that expands Ockham’s service offerings and resources to a global scale.
Program Life-Cycle Management: From initial contact through project closure, Senior Management is involved and participates in every step of the relationship. With decades of business and technical experience in all phases and aspects of drug development, these team members assure the client not only of expert guidance, but that the Ockham team will stay with the project to its successful conclusion. |